Clinical Trial Update: Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describes ongoing study of heparin anticoagulation in patients supported with veno-venous ECMO (VV-ECMO) for respiratory failure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: Baylor Research Institute | Conditions: ECMO, Heparin | Phase 4 | Status: ACTIVE_NOT_RECRUITING